The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Starting today, the United States will no longer subsidize the health care of foreign countries, which is what we were doing,” Trump said before signing the executive order, which he ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

In a post on his Truth Social platform on Sunday, Trump said the order, which he proceeded to sign Monday morning, will ...

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...

U.S. futures surged Monday after the U.S. and China announced they were suspending for 90 days most of the sharp tariff hikes ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

From innovative treatments to unequal access to medicine, I cover health topics and keep an eye on Switzerland's Health Valley. I'm Swiss-Turkish, and have a background in communications ...

The shares closed the day at $245.49, down 30.5% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

AbbVie Inc.'s ABBV stock is trading higher after it released better-than-expected Q1 earnings and raised its 2025 forecast. The company reported an adjusted EPS of $2.46 on Friday, up 6.5% year ...